These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8166571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quinolone pharmacokinetics and metabolism.
    Lode H, Höffken G, Boeckk M, Deppermann N, Borner K, Koeppe P.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP, Leroy A, Moulin B, Dhib M, Borsa-Lebas F, Humbert G.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988 Oct; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 5. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F, Takahashi T, Morita M.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract] [Full Text] [Related]

  • 6. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ, Vree TB, Baars AM, van Herwaarden CL.
    Drugs; 1987 Feb; 34 Suppl 1():159-69. PubMed ID: 3481317
    [Abstract] [Full Text] [Related]

  • 7. [Excretion of fluoroquinolones into saliva].
    Kelentey BA, Kelentey BJ, Fekete I, Kozma J.
    Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
    [Abstract] [Full Text] [Related]

  • 8. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
    Griffiths NM, Hirst BH, Simmons NL.
    J Pharmacol Exp Ther; 1994 May; 269(2):496-502. PubMed ID: 8182517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative pharmacokinetics of new quinolones.
    Lode H, Höffken G, Prinzing C, Glatzel P, Wiley R, Olschewski P, Sievers B, Reimnitz D, Borner K, Koeppe P.
    Drugs; 1987 May; 34 Suppl 1():21-5. PubMed ID: 3481323
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G, Gaillot J.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC, Callegan MC, Engel LS, Shimomura Y, Jasheway DW, O'Callaghan RJ, Hill JM.
    Jpn J Ophthalmol; 1996 Oct; 40(1):123-6. PubMed ID: 8739510
    [Abstract] [Full Text] [Related]

  • 14. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG, Mutlu I, Ozyazgan S, Gök A, Yigit U, Ozüner Z, Senses V, Pekel H.
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [Abstract] [Full Text] [Related]

  • 15. Binding characteristics of fluoroquinolones to synthetic levodopa melanin.
    Ono C, Tanaka M.
    J Pharm Pharmacol; 2003 Aug; 55(8):1127-33. PubMed ID: 12956903
    [Abstract] [Full Text] [Related]

  • 16. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y, Nishino T.
    Drugs Exp Clin Res; 1989 Aug; 15(2):53-8. PubMed ID: 2661182
    [Abstract] [Full Text] [Related]

  • 17. [Fluoroquinolones].
    Baykal M, Akalin E.
    Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of fluorinated 4-quinolones in the aged.
    Norrby SR, Ljungberg B.
    Rev Infect Dis; 1989 Apr; 11 Suppl 5():S1102-6. PubMed ID: 2672244
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
    Daniel JP, Moulin B, Christmann D.
    Ann Pharm Fr; 2004 May; 62(3):177-85. PubMed ID: 15243351
    [Abstract] [Full Text] [Related]

  • 20. [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].
    Smirnova LB, Sokolova VI.
    Antibiot Khimioter; 2000 May; 45(7):14-6. PubMed ID: 10987102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.